These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19019272)

  • 1. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.
    Al-Reesi A; Al-Zadjali N; Perry J; Fergusson D; Al-Shamsi M; Al-Thagafi M; Stiell I
    CJEM; 2008 May; 10(3):215-23. PubMed ID: 19019272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.
    Mostafaie K; Bedenis R; Harrington D
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006342. PubMed ID: 25879091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
    Perez MI; Musini VM; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction.
    Delaney JA; Daskalopoulou SS; Suissa S
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):1-6. PubMed ID: 18949804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.
    Steinman MA; Zullo AR; Lee Y; Daiello LA; Boscardin WJ; Dore DD; Gan S; Fung K; Lee SJ; Komaiko KD; Mor V
    JAMA Intern Med; 2017 Feb; 177(2):254-262. PubMed ID: 27942713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
    Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
    Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate.
    Karlson BW; Herlitz J; Hjalmarson A
    Clin Cardiol; 1994 Jun; 17(6):311-6. PubMed ID: 7915221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.
    Gluud LL; Krag A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD004544. PubMed ID: 22895942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
    Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
    JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.